Tilapia Piscidin 4 (TP4) Stimulates Cell Proliferation and Wound Closure in MRSA-Infected Wounds in Mice

Hang-Ning Huang1, Yi-Lin Chan2, Chang-Jer Wu3

  • 1Marine Research Station, Institute of Cellular and Organismic Biology, Academia Sinica, 23-10 Dahuen Road, Jiaushi, Ilan 262, Taiwan. henryhw910@yahoo.com.tw.

Marine Drugs
|May 9, 2015
PubMed

Insights

Tilapia piscidin 4 (TP4), an antimicrobial peptide, promotes wound healing and combats MRSA infections in mice. This peptide stimulates cell proliferation and tissue repair, suggesting its potential as a novel wound dressing agent.

Area of Science:

  • Biochemistry
  • Immunology
  • Dermatology

Background:

  • Antimicrobial peptides (AMPs) are crucial for innate immunity and possess diverse biological functions.
  • Tilapia piscidin 4 (TP4), an AMP from Nile tilapia, exhibits antibacterial properties and modulates immune responses.
  • The role of TP4 in wound healing and keratinocyte/fibroblast proliferation requires further investigation.

Purpose of the Study:

  • To investigate the effects of TP4 on wound closure in mice.
  • To analyze the impact of TP4 on keratinocyte (HaCaT) and fibroblast (Hs-68) cell proliferation.
  • To evaluate the therapeutic potential of TP4 against MRSA infections and its toxicity profile.

Main Methods:

  • In vitro assays assessing cell proliferation and gene expression (collagen I, III, KGF) in HaCaT and Hs-68 cells treated with TP4.
  • In vivo studies using mouse models to assess TP4's efficacy against peritonitis and wound infections caused by MRSA.
  • Toxicological evaluation of TP4 in mice, monitoring for adverse effects and organ toxicity.

Main Results:

  • TP4 significantly stimulated proliferation and upregulated collagen I, collagen III, and KGF gene expression in Hs-68 cells at concentrations as low as 6.25 µg/mL.
  • TP4 demonstrated high efficacy in combating MRSA-induced peritonitis and wound infections in mice.
  • No adverse behavioral effects or liver/kidney toxicity were observed in TP4-treated mice.

Conclusions:

  • TP4 enhances survival rates in MRSA-infected mice through combined antimicrobial and wound closure activities.
  • TP4-mediated wound healing involves growth factors like EGF, TGF, and VEGF, promoting tissue homeostasis.
  • TP4 shows promise as a potential topical agent for wound dressing applications.